Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a standalone company. The new diabetes company will focus on accelerating innovation ...

Medtronic announced Wednesday that it will spin off its diabetes business into a standalone company. The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, ...

Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart insulin pens with a glucose sensor made by Abbott.

When you live with diabetes, you have to be nimble with numbers. Each day, the millions of Americans living with the disease must diligently calculate carbohydrates and sugars, internally debating how ...

DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for the MiniMed™ 780G system with ...

Medtronic this week said it plans to cleave off its diabetes business into a separate, publicly traded company. The new, yet-to-be-named company would be headquartered in California and have about ...

Medtronic, a global healthcare technology company, announced that MiniMed is the name for the planned new diabetes company following the intended separation. The name honors the company's roots, ...

Medtronic plc revealed plans to spin off its underperforming diabetes unit as a separate public company during its fourth quarter 2025 earnings call on May 21. The company expects to complete the ...

Medtronic’s (NYSE: MDT) diabetes segment, which sells insulin pumps, continuous glucose monitoring systems, and consumables has seen its revenue rise at a slower pace of 1.4% annually from $2.4 ...

Abbott and Medtronic are typically regarded as competitors, but the two medical device giants have recently decided to join forces. Last week, the two companies teamed up to collaborate on a ...

MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily ...

As 2026 begins, the good news is that Medtronic hasn't peaked yet. There are still solid reasons to consider buying shares of ...